XML 54 R40.htm IDEA: XBRL DOCUMENT v3.22.0.1
Equity and Cash Incentive Programs (Tables)
 12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense Stock-based compensation expense relating to all stock-based incentive plans was as follows:
 Years Ended December 31,
 202120202019
Stock-based compensation expense$23,178 $19,536 $10,250 
Tax benefit(5,257)(4,478)(2,153)
Stock-based compensation expense, net of tax$17,921 $15,058 $8,097 
Schedule of Activity Related to SARs Outstanding A summary of activity relating to SARs outstanding for the year ended December 31, 2021, is as follows:
 SARs
 SharesWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Term
(in years)		Aggregate Intrinsic Value
(in thousands)
Outstanding at January 1, 2021415,331 $29.67 
Forfeited / expired(2,134)25.27 
Exercised(19,674)24.73 
Outstanding at December 31, 2021393,523 $29.94 4.2$— 
Exercisable at December 31, 2021393,523 $29.94 4.2$— 
Schedule of Other Information Related to the Exercise of SARs
Other information regarding the exercise of SARs is presented below:
(in thousands)202120202019
SARs:
Fair value of SARs that became exercisable$— $878 $662 
Aggregate intrinsic value of SARs exercised71 — 629 
Schedule of Fair Value Used in Determining Stock-Based Compensation Expense The fair value used in determining stock-based compensation expense of the performance share awards issued in 2021, 2020, and 2019, is as follows:
Performance shares:202120202019
Fair value per share at date of grant$26.32 $14.55 $57.43 
The fair value and average attainment used in determining stock-based compensation expense of the performance shares issued in 2021 and 2020 are as follows:
Performance shares:20212020
Fair value per share at date of grant$17.61 $— 
Average attainment rate reflected in expense100 %— %
Schedule of Performance Shares
A summary of activity for ChampionX’s performance share awards under the 2018 Plan for the year ended December 31, 2021, is as follows:
 SharesWeighted-Average
Grant-Date
Fair Value
Unvested at January 1, 2021278,763 $35.95 
Granted333,037 21.97 
Forfeited(5,678)21.97 
Vested(148,341)50.50 
Performance adjustment (1)
47,728 56.32 
Unvested at December 31, 2021505,509 $24.26 
_______________________
(1)     Represents the additional shares that were issued to participants upon vesting of the awards due to the performance factor being exceeded for the three-year performance period.
Schedule of Restricted Stock Unit Activity
A summary of activity for restricted stock units for the year ended December 31, 2021, is as follows:
 SharesWeighted-Average
Grant-Date
Fair Value
Unvested at January 1, 20212,669,779 $14.04 
Granted901,485 18.10 
Forfeited(126,077)13.70 
Vested(1,103,080)15.28 
Unvested at December 31, 20212,342,107 $14.49 
Schedule of Non-Qualified Stock Options A summary of activity for non-qualified stock options for the year ended December 31, 2021 is as follows:
 Non-Qualified Stock Options
 SharesWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Term
(in years)		Aggregate Intrinsic Value
(in thousands)
Outstanding at January 1, 20217,175,040 $6.01 
Granted— — 
Forfeited / expired(39,990)7.54 
Exercised(1,646,397)5.38 
Outstanding at December 31, 20215,488,653 $6.18 5.0$75,984 
Exercisable at December 31, 20215,487,875 $6.18 5.0$75,975